Pinned Tweet
I never planned to start a company. I just wanted a better way to keep up with new research in cardiology.
So I built @CurrentCardio. Then I realised the same problem exists in other specialties.
That became CInterval Research.
Why doesn’t CInterval cover all new research?
Because that’s what PubMed is for.
Each platform follows 20–40 selected journals rather than trying to cover everything.
Some good papers won’t be included. It’s a deliberate trade-off.
The journal lists aren’t set in stone, though. Suggestions are always welcome!
cinterval.com
1
2
CurrentEndo is now live.
The fourth CInterval platform and the largest yet: 14 topics across endocrinology, diabetes and obesity, 34 journals and 17,000+ Briefs, composed by AI from published abstracts.
Free and ad-free.
Next up: nephrology.
currentendo.com
One thing I've learned while building CInterval:
The hardest AI errors aren't always incorrect numbers.
Sometimes the number is right, but assigned to the wrong group. Or a finding is presented in the opposite direction.
That's why verification needs more than just checking the numbers.
PubMed is an essential tool for medical research. It already offers literature searches and alerts for new publications.
So why am I building CInterval?
CInterval does not replace PubMed.
For systematic reviews and meta-analyses, comprehensive searches across relevant databases remain essential.
The Briefs are based on published abstracts, without added clinical interpretation. The original paper remains the source.
1
1
Three platforms are live:
CurrentCardio – cardiology
CurrentAnesthesia – anesthesia, perioperative medicine, pain and critical care
CurrentRheuma – rheumatology
Adding a new specialty every few weeks. All free.
cinterval.com/?utm_source=x
At CInterval, we follow major medical conferences across specialties, including #AHA26 #ScientificSessions26.
Our Briefs aren't based on conference slides or press releases. We wait for the published abstract to become available in PubMed.
Sometimes that takes a little longer, but it keeps the process consistent.
Post 1/3
New from #AHA26 #ScientificSessions26.
Seven studies now available as structured Briefs on CurrentCardio:
ISCHEMIA-EXTEND
ISCHEMIA-CKD EXTEND
COAST-AF
Ez-PAVE
IRONMET-HFpEF
LATENT
DAPT-SHOCK-AMI imaging substudy
21
I've spent quite a bit of time figuring out how AI should handle medical research abstracts.
For CInterval, I've decided AI shouldn't interpret the findings, only present what's reported.
How much interpretation should AI provide when presenting medical research?
One study, two specialties.
DAPT-SHOCK-AMI is an antiplatelet trial for cardiologists.
For anesthesia and critical care, it's a question of whether oral drugs work in shock.
So it's on both @CurrentCardio and @CurrentAnesth.
Just published at #AHA26: DAPT-SHOCK-AMI (Lancet), IV cangrelor vs crushed ticagrelor in AMI with cardiogenic shock
605 pts, double-blind
Death/MI/stroke, 30 d: 38% vs 41%
Diff −4 pp (90% CI −10 to 3); NI margin 1 pp not met
Platelet inhibition after PCI: 100% vs 22%
currentcardio.com/studies/ca…
1
38
CInterval Research retweeted
Just published at #AHA26: ISCHEMIA-EXTEND, 11-year follow-up (JAMA)
5,179 patients, chronic coronary disease + moderate/severe ischemia
Invasive vs conservative strategy
All-cause death at 11 y: 25.8% vs 26.9%
Diff −1.0 pp (95% CI −4.2 to 2.1)
aHR 0.97 (0.86–1.09)
currentcardio.com/studies/lo…
CurrentRheuma is live — our third platform, after CurrentCardio and CurrentAnesthesia.
Structured Briefs of new rheumatology research from 23 journals, a personalized Weekly and a searchable archive of 10,368 Briefs. Free.
currentrheuma.com
1
24
Free, specialty-specific platforms that present newly published studies as structured Briefs: study design, population, results and plots.
Live now for cardiology, anesthesiology and rheumatology, with more specialties to come.
cinterval.com/?utm_source=x&…


